[Substances with antineoplastic effect. 29. N-delta-6-purinylthio valeryl-amino acids and analogous dipeptide and triglycerin derivatives].
D000596:Amino Acids / Q000138:chemical synthesis / Q000627:therapeutic use*; D000818:Animals; D000970:Antineoplastic Agents / Q000138:chemical synthesis* / Q000627:therapeutic use* / Q000633:toxicity; D004151:Dipeptides / Q000138:chemical synthesis / Q000627:therapeutic use*; D004952:Esters / Q000138:chemical synthesis; D005260:Female; D008325:Mammary Neoplasms, Experimental / Q000188:drug therapy; D015122:Mercaptopurine / Q000627:therapeutic use; D051379:Mice; D009374:Neoplasms, Experimental / Q000188:drug therapy; D051381:Rats; D012509:Sarcoma / Q000188:drug therapy; D012510:Sarcoma 180; D012517:Sarcoma, Yoshida / Q000188:drug therapy; D014280:Triglycerides / Q000138:chemical synthesis / Q000627:therapeutic use*
D000596:Amino Acids; D000970:Antineoplastic Agents; D004151:Dipeptides; D004952:Esters; D014280:Triglycerides; D015122:Mercaptopurine
Substanzen mit antineoplastischer Wirkung. 29. N-delta-6-Purinylthio valeryl-amino-säuren und analoge Dipeptid- und Triglycin-Derivate.